{"id":28605,"date":"2025-11-04T16:34:00","date_gmt":"2025-11-04T15:34:00","guid":{"rendered":"https:\/\/eraportal.sk\/horizont-europa\/?post_type=aktualita&#038;p=28605"},"modified":"2025-11-04T16:51:58","modified_gmt":"2025-11-04T15:51:58","slug":"era4health-predbezne-oznamenie-vyzvy-trials4health","status":"publish","type":"aktualita","link":"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/","featured_media":0,"template":"","tags":[382],"oblast-horizont":[181,275],"class_list":["post-28605","aktualita","type-aktualita","status-publish","hentry","tag-vyzva","oblast-horizont-klaster-1-zdravie","oblast-horizont-partnerstva-oblast-zdravie"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ERA4Health \u2013 predbe\u017en\u00e9 ozn\u00e1menie v\u00fdzvy Trials4Health - Horizont Eur\u00f3pa<\/title>\n<meta name=\"description\" content=\"CVTI SR d\u00e1va do pozornosti pl\u00e1novan\u00e9 vyhl\u00e1senie siedmej spolo\u010dnej nadn\u00e1rodnej v\u00fdzvy zameran\u00fa na klinick\u00e9 \u0161t\u00fadie Eur\u00f3pskeho partnerstva pre podporu eur\u00f3pskeho v\u00fdskumn\u00e9ho priestoru v oblasti zdravia - Fostering a European Research Area for Health (ERA4Health) pod n\u00e1zvom:\u201cMulti-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases\u201d (Trials4Health).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ERA4Health \u2013 predbe\u017en\u00e9 ozn\u00e1menie v\u00fdzvy Trials4Health - Horizont Eur\u00f3pa\" \/>\n<meta property=\"og:description\" content=\"CVTI SR d\u00e1va do pozornosti pl\u00e1novan\u00e9 vyhl\u00e1senie siedmej spolo\u010dnej nadn\u00e1rodnej v\u00fdzvy zameran\u00fa na klinick\u00e9 \u0161t\u00fadie Eur\u00f3pskeho partnerstva pre podporu eur\u00f3pskeho v\u00fdskumn\u00e9ho priestoru v oblasti zdravia - Fostering a European Research Area for Health (ERA4Health) pod n\u00e1zvom:\u201cMulti-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases\u201d (Trials4Health).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/\" \/>\n<meta property=\"og:site_name\" content=\"Horizont Eur\u00f3pa\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-04T15:51:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2025\/11\/Obrazok1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"287\" \/>\n\t<meta property=\"og:image:height\" content=\"95\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/\",\"url\":\"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/\",\"name\":\"ERA4Health \u2013 predbe\u017en\u00e9 ozn\u00e1menie v\u00fdzvy Trials4Health - Horizont Eur\u00f3pa\",\"isPartOf\":{\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2025\/11\/Obrazok1.png\",\"datePublished\":\"2025-11-04T15:34:00+00:00\",\"dateModified\":\"2025-11-04T15:51:58+00:00\",\"description\":\"CVTI SR d\u00e1va do pozornosti pl\u00e1novan\u00e9 vyhl\u00e1senie siedmej spolo\u010dnej nadn\u00e1rodnej v\u00fdzvy zameran\u00fa na klinick\u00e9 \u0161t\u00fadie Eur\u00f3pskeho partnerstva pre podporu eur\u00f3pskeho v\u00fdskumn\u00e9ho priestoru v oblasti zdravia - Fostering a European Research Area for Health (ERA4Health) pod n\u00e1zvom:\u201cMulti-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases\u201d (Trials4Health).\",\"breadcrumb\":{\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/#primaryimage\",\"url\":\"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2025\/11\/Obrazok1.png\",\"contentUrl\":\"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2025\/11\/Obrazok1.png\",\"width\":287,\"height\":95},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Domovsk\u00e1 str\u00e1nka\",\"item\":\"https:\/\/eraportal.sk\/horizont-europa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aktuality\",\"item\":\"https:\/\/eraportal.sk\/horizont-europa\/aktuality-archiv\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ERA4Health \u2013 predbe\u017en\u00e9 ozn\u00e1menie v\u00fdzvy Trials4Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/#website\",\"url\":\"https:\/\/eraportal.sk\/horizont-europa\/\",\"name\":\"Horizont Eur\u00f3pa\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/eraportal.sk\/horizont-europa\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/#organization\",\"name\":\"Horizont Eur\u00f3pa\",\"url\":\"https:\/\/eraportal.sk\/horizont-europa\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2024\/02\/Favicon_HEU.png\",\"contentUrl\":\"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2024\/02\/Favicon_HEU.png\",\"width\":512,\"height\":512,\"caption\":\"Horizont Eur\u00f3pa\"},\"image\":{\"@id\":\"https:\/\/eraportal.sk\/horizont-europa\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ERA4Health \u2013 predbe\u017en\u00e9 ozn\u00e1menie v\u00fdzvy Trials4Health - Horizont Eur\u00f3pa","description":"CVTI SR d\u00e1va do pozornosti pl\u00e1novan\u00e9 vyhl\u00e1senie siedmej spolo\u010dnej nadn\u00e1rodnej v\u00fdzvy zameran\u00fa na klinick\u00e9 \u0161t\u00fadie Eur\u00f3pskeho partnerstva pre podporu eur\u00f3pskeho v\u00fdskumn\u00e9ho priestoru v oblasti zdravia - Fostering a European Research Area for Health (ERA4Health) pod n\u00e1zvom:\u201cMulti-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases\u201d (Trials4Health).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/","og_locale":"sk_SK","og_type":"article","og_title":"ERA4Health \u2013 predbe\u017en\u00e9 ozn\u00e1menie v\u00fdzvy Trials4Health - Horizont Eur\u00f3pa","og_description":"CVTI SR d\u00e1va do pozornosti pl\u00e1novan\u00e9 vyhl\u00e1senie siedmej spolo\u010dnej nadn\u00e1rodnej v\u00fdzvy zameran\u00fa na klinick\u00e9 \u0161t\u00fadie Eur\u00f3pskeho partnerstva pre podporu eur\u00f3pskeho v\u00fdskumn\u00e9ho priestoru v oblasti zdravia - Fostering a European Research Area for Health (ERA4Health) pod n\u00e1zvom:\u201cMulti-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases\u201d (Trials4Health).","og_url":"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/","og_site_name":"Horizont Eur\u00f3pa","article_modified_time":"2025-11-04T15:51:58+00:00","og_image":[{"width":287,"height":95,"url":"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2025\/11\/Obrazok1.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/","url":"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/","name":"ERA4Health \u2013 predbe\u017en\u00e9 ozn\u00e1menie v\u00fdzvy Trials4Health - Horizont Eur\u00f3pa","isPartOf":{"@id":"https:\/\/eraportal.sk\/horizont-europa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/#primaryimage"},"image":{"@id":"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/#primaryimage"},"thumbnailUrl":"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2025\/11\/Obrazok1.png","datePublished":"2025-11-04T15:34:00+00:00","dateModified":"2025-11-04T15:51:58+00:00","description":"CVTI SR d\u00e1va do pozornosti pl\u00e1novan\u00e9 vyhl\u00e1senie siedmej spolo\u010dnej nadn\u00e1rodnej v\u00fdzvy zameran\u00fa na klinick\u00e9 \u0161t\u00fadie Eur\u00f3pskeho partnerstva pre podporu eur\u00f3pskeho v\u00fdskumn\u00e9ho priestoru v oblasti zdravia - Fostering a European Research Area for Health (ERA4Health) pod n\u00e1zvom:\u201cMulti-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases\u201d (Trials4Health).","breadcrumb":{"@id":"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/"]}]},{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/#primaryimage","url":"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2025\/11\/Obrazok1.png","contentUrl":"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2025\/11\/Obrazok1.png","width":287,"height":95},{"@type":"BreadcrumbList","@id":"https:\/\/eraportal.sk\/horizont-europa\/aktualita\/era4health-predbezne-oznamenie-vyzvy-trials4health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Domovsk\u00e1 str\u00e1nka","item":"https:\/\/eraportal.sk\/horizont-europa\/"},{"@type":"ListItem","position":2,"name":"Aktuality","item":"https:\/\/eraportal.sk\/horizont-europa\/aktuality-archiv\/"},{"@type":"ListItem","position":3,"name":"ERA4Health \u2013 predbe\u017en\u00e9 ozn\u00e1menie v\u00fdzvy Trials4Health"}]},{"@type":"WebSite","@id":"https:\/\/eraportal.sk\/horizont-europa\/#website","url":"https:\/\/eraportal.sk\/horizont-europa\/","name":"Horizont Eur\u00f3pa","description":"","publisher":{"@id":"https:\/\/eraportal.sk\/horizont-europa\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eraportal.sk\/horizont-europa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sk-SK"},{"@type":"Organization","@id":"https:\/\/eraportal.sk\/horizont-europa\/#organization","name":"Horizont Eur\u00f3pa","url":"https:\/\/eraportal.sk\/horizont-europa\/","logo":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/eraportal.sk\/horizont-europa\/#\/schema\/logo\/image\/","url":"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2024\/02\/Favicon_HEU.png","contentUrl":"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2024\/02\/Favicon_HEU.png","width":512,"height":512,"caption":"Horizont Eur\u00f3pa"},"image":{"@id":"https:\/\/eraportal.sk\/horizont-europa\/#\/schema\/logo\/image\/"}}]}},"acf":{"nadpis":"ERA4Health \u2013 predbe\u017en\u00e9 ozn\u00e1menie v\u00fdzvy Trials4Health","opis":"<img class=\"alignnone size-full wp-image-28606\" src=\"https:\/\/eraportal.sk\/horizont-europa\/wp-content\/uploads\/sites\/4\/2025\/11\/Obrazok1.png\" alt=\"\" width=\"287\" height=\"95\" \/>\r\n\r\nCVTI SR d\u00e1va do pozornosti pl\u00e1novan\u00e9 vyhl\u00e1senie siedmej spolo\u010dnej nadn\u00e1rodnej v\u00fdzvy zameran\u00fa na klinick\u00e9 \u0161t\u00fadie <em>Eur\u00f3pskeho partnerstva pre podporu eur\u00f3pskeho v\u00fdskumn\u00e9ho priestoru v\u00a0oblasti zdravia<\/em> - <em>Fostering a European Research Area for Health (ERA4Health) <\/em>pod n\u00e1zvom:\r\n\r\n<strong>\u201cMulti-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases\u201d (Trials4Health).<\/strong>\r\n\r\n<strong>Cie\u013e v\u00fdzvy<\/strong>\r\n<ul>\r\n \t<li>Podpori\u0165 randomizovan\u00e9 interven\u010dn\u00e9, klinick\u00e9 \u0161t\u00fadie iniciovan\u00e9 v\u00fdskumn\u00edkmi z\u00a0viacer\u00fdch kraj\u00edn (Investigator-Initiated Clinical Studies \u2013 IICS), ktor\u00e9 s\u00fa navrhnut\u00e9 ako pragmatick\u00e9 komparat\u00edvne \u0161t\u00fadie \u00fa\u010dinnosti a\/alebo \u0161t\u00fadie op\u00e4tovn\u00e9ho vyu\u017eitia liekov (drug repurposing).<\/li>\r\n \t<li>Podpori\u0165 a umo\u017eni\u0165 nadn\u00e1rodn\u00fa spolupr\u00e1cu medzi v\u00fdskumn\u00fdmi t\u00edmami z oblasti klinick\u00e9ho v\u00fdskumu a\u00a0v\u00fdskumu z\u00a0oblasti verejn\u00e9ho zdravia (nemocnice, zariadenia verejnej zdravotnej starostlivosti, a\u00a0\u010fal\u0161ie zdravotn\u00edcke organiz\u00e1cie), ktor\u00e9 realizuj\u00fa medzin\u00e1rodn\u00e9 IICS, \u010di u\u017e ide o \u0161t\u00fadie komparat\u00edvnej \u00fa\u010dinnosti, alebo \u0161t\u00fadie nov\u00e9ho vyu\u017eitia liekov.<\/li>\r\n<\/ul>\r\nKlinick\u00e9 \u0161t\u00fadie vykon\u00e1van\u00e9 na priame komer\u010dn\u00e9 \u00fa\u010dely a\/alebo v in\u00fdch lek\u00e1rskych oblastiach, ako s\u00fa uveden\u00e9 vy\u0161\u0161ie, nespadaj\u00fa do p\u00f4sobnosti tejto v\u00fdzvy.\r\n\r\nFinancovan\u00e9 bud\u00fa len nadn\u00e1rodn\u00e9 projekty. V\u00fdzva bude dvojkolov\u00e1.\r\n\r\n<strong>Predbe\u017en\u00fd zoznam participuj\u00facich kraj\u00edn<\/strong>\r\n\r\nNemecko, Taliansko, Loty\u0161sko, Litva, N\u00f3rsko, Po\u013esko, Rumunsko, Slovensko, \u0160panielsko, \u0160v\u00e9dsko, Turecko, Spojen\u00e9 kr\u00e1\u013eovstvo Ve\u013ekej Brit\u00e1nie a Severn\u00e9ho \u00cdrska a USA\r\n\r\n<strong>\u010casov\u00fd harmonogram v\u00fdzvy<\/strong>\r\n<table>\r\n<tbody>\r\n<tr>\r\n<td width=\"217\">6. november 2025<\/td>\r\n<td width=\"380\">Zverejnenie v\u00fdzvy<\/td>\r\n<\/tr>\r\n<tr>\r\n<td width=\"217\">13. november 2025\r\n\r\n30. november<\/td>\r\n<td width=\"380\">Informa\u010dn\u00fd webin\u00e1r\r\n\r\nTerm\u00edn pre informovanie ECRIN o\u00a0pripravovanom n\u00e1vrhu projektu a\u00a0vyjadrenie z\u00e1ujmu o spolupr\u00e1cu<\/td>\r\n<\/tr>\r\n<tr>\r\n<td width=\"217\">27. janu\u00e1r 2026, 16:00<\/td>\r\n<td width=\"380\">Term\u00edn na predlo\u017eenie predbe\u017en\u00fdch n\u00e1vrhov<\/td>\r\n<\/tr>\r\n<tr>\r\n<td width=\"217\">17. apr\u00edl 2026<\/td>\r\n<td width=\"380\">Ozn\u00e1menie v\u00fdsledkov (v\u00fdzva na predlo\u017eenie \u00fapln\u00e9ho n\u00e1vrhu)<\/td>\r\n<\/tr>\r\n<tr>\r\n<td width=\"217\">17. j\u00fan 2026, 16:00<\/td>\r\n<td width=\"380\">Term\u00edn na predlo\u017eenie \u00fapln\u00e9ho n\u00e1vrhu\r\n\r\n&nbsp;<\/td>\r\n<\/tr>\r\n<tr>\r\n<td width=\"217\">24. august \u2013 4. september 2026<\/td>\r\n<td width=\"380\">Rebuttal stage<\/td>\r\n<\/tr>\r\n<tr>\r\n<td width=\"217\">Koniec okt\u00f3bra<\/td>\r\n<td width=\"380\">Ozn\u00e1menie rozhodnut\u00ed o financovan\u00ed n\u00e1vrhov<\/td>\r\n<\/tr>\r\n<tr>\r\n<td width=\"217\">December 2026 \u2013 m\u00e1j 2027<\/td>\r\n<td width=\"380\">Predpokladan\u00fd za\u010diatok projektu (pod\u013ea n\u00e1rodn\u00fdch pravidiel)<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n\u010eal\u0161ie inform\u00e1cie k\u00a0v\u00fdzve n\u00e1jdete v\u00a0ofici\u00e1lnom texte <a href=\"https:\/\/era4health.eu\/calls\/pre_trials4health.php\">predbe\u017en\u00e9ho ozn\u00e1menia<\/a> na webovom s\u00eddle partnerstva <a href=\"https:\/\/era4health.eu\/calls\/pre_preventoo.php\">ERA4Health<\/a>.\r\n\r\nUpozor\u0148ujeme, \u017ee uveden\u00e9 inform\u00e1cie s\u00fa predbe\u017en\u00e9 a podrobnosti m\u00f4\u017eu by\u0165 pred zverejnen\u00edm v\u00fdzvy zmenen\u00e9. Fin\u00e1lne znenie v\u00fdzvy vr\u00e1tane krit\u00e9ri\u00ed opr\u00e1vnenosti a hodnotenia bud\u00fa zverejnen\u00e9 pri ofici\u00e1lnom vyhl\u00e1sen\u00ed v\u00fdzvy v novembri 2025.\r\n\r\nZverejnen\u00e9: 4.11.2025, jf","kratky_opis":"CVTI SR d\u00e1va do pozornosti pl\u00e1novan\u00e9 vyhl\u00e1senie siedmej spolo\u010dnej nadn\u00e1rodnej v\u00fdzvy zameran\u00fa na klinick\u00e9 \u0161t\u00fadie Eur\u00f3pskeho partnerstva pre podporu eur\u00f3pskeho v\u00fdskumn\u00e9ho priestoru v\u00a0oblasti zdravia - Fostering a European Research Area for Health (ERA4Health)","oblast":["181","275"],"zobrazit_velke_v_newsletteri":false,"reminder":false,"newsletter_thumbnail":""},"_links":{"self":[{"href":"https:\/\/eraportal.sk\/horizont-europa\/wp-json\/wp\/v2\/aktuality\/28605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eraportal.sk\/horizont-europa\/wp-json\/wp\/v2\/aktuality"}],"about":[{"href":"https:\/\/eraportal.sk\/horizont-europa\/wp-json\/wp\/v2\/types\/aktualita"}],"acf:term":[{"embeddable":true,"taxonomy":"oblast-horizont","href":"https:\/\/eraportal.sk\/horizont-europa\/wp-json\/wp\/v2\/oblast-horizont\/275"},{"embeddable":true,"taxonomy":"oblast-horizont","href":"https:\/\/eraportal.sk\/horizont-europa\/wp-json\/wp\/v2\/oblast-horizont\/181"}],"wp:attachment":[{"href":"https:\/\/eraportal.sk\/horizont-europa\/wp-json\/wp\/v2\/media?parent=28605"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eraportal.sk\/horizont-europa\/wp-json\/wp\/v2\/tags?post=28605"},{"taxonomy":"oblast-horizont","embeddable":true,"href":"https:\/\/eraportal.sk\/horizont-europa\/wp-json\/wp\/v2\/oblast-horizont?post=28605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}